Advertisement
 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Dosing Of Kaletra
Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts
On PEP, Truvada Kaletra, Missed 1 dose of Kaletralast night i missed 1 dose of kaletra and went to bed. When i woke up i continued as normal with dosing Truvada and Kaletra. I am 13 days in and started PEP 16 hours after exposure. Will that missed dose of Kaletra make a difference and allow the...
Response from Benjamin Young, M.D., Ph.D.
Rocky Mountain CARES
Hello and thanks for posting.Missing a single dose of your Kaletra won't have any significant impact on the effectiveness of PEP. Indeed, Kaletra can be taken once-daily, so should this happen again, I'd consider taking all of your meds...
Read more »
missed a dose of kaletraon my 2nd week of PEP... taking truvada and 2 kaletra in the evening and 2 kaletra in the... Read more »Dosing Kaletra / TruvadaBen...Ben, have a question regarding my current once a day dosing of Kaletra 4tabs daily and... Read more »
Articles
Abbott Receives FDA Approval for Lower-Dose of Antiretroviral Kaletra for ChildrenAbbott Laboratories on Monday announced that it has received FDA approval to market and sell a lower-dose version of its antiretroviral drug Kaletra for children, the Chicago Sun-Times reports (Knowles, Chicago Sun-Times , 11/13). The tablet... Read more »
Abbott Laboratories Asks Regulators to Approve New Dose of AIDS Drug Kaletra for ChildrenAbbott Laboratories on Friday said it is seeking approval from the U.S. Food and Drug Administration and European regulators for lower-dose versions of its AIDS drug Kaletra, which is also marketed as Aluvia. The new version is expected to be... Read more »
New Kaletra (Lopinavir/Ritonavir) Tablets and Oral Solution Once Daily Dosing Regimen in Certain Adult PatientsOn April 27, 2010, FDA approved a new dosing regimen for Kaletra (lopinavir/ritonavir) tablets and oral solution. Kaletra can be administered once daily (800/200 mg) in patients with less than three lopinavir resistance associated substitutions.... Read more »
Elvitegravir in Treatment-Experienced PeopleElvitegravir is an emerging integrase inhibitor. When elvitegravir is taken with a low dose of the drug ritonavir (Norvir), the concentration of elvitegravir in the blood rises and remains elevated for about a day. The manufacturer of elvitegravir,... Read more »
Connect With Others
New Kaletra Formulation.....
Posted by Anonymous, 3 Replies
Hello.I am looking at changing from Sustiva to Kaletra (My Nuke backbone is Truvada), however I have concerns about the side effect profile of Kaletra. I hear that the newer formulation of Kaletra has less side effects that the old one - has anyone... Read more » First Regimen = Sustiva + Combivir + Kaletra?
Posted by placation, 4 Replies
Hey guys (and gals). I am sure this has been addressed in some other post through some other thread in the past, but it would take forever to try to find those messages. So, here's my question and my issues...My doc subscribed Sustiva + Combivir +... Read more » kaletra
Posted by Lovinlife, 3 Replies
Has anybody taken kaletra? I just started it. Am wondering what I can expect.......
Read more »
Use of medication Kaletra
Posted by Anonymous, 1 Reply
WANTED "KALETRA" USERSIndividuals currently taking the medication KALETRA are invited to participate in a "quality of life" study, consisting of a brief telephone discussion. Confidentiality is guaranteed. Compensation of $20.00 (U.S.). Please... Read more »
Tools
Advertisement Advertisement
Resource Centers
Guides for People With HIV
|
My Health Tracker
Assess Your Risk for HIV
Find Local HIV/AIDS Services
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
